Table 1.
Patients discharged, n (%) | Tocilizumab N = 294 |
Placebo N = 144 |
||
---|---|---|---|---|
Weekly | Cumulative | Weekly | Cumulative | |
Day 7 | 55 (18·7) | 55 (18·7) | 19 (13·2) | 19 (13·2) |
Day 14 | 58 (19·7) | 113 (38·4) | 24 (16·7) | 43 (29·9) |
Day 21 | 28 (9·5) | 141 (48·0) | 16 (11·1) | 59 (41·0) |
Day 28 | 16 (5·4) | 157 (53·4) | 7 (4·9) | 66 (45·8) |
Day 35 | 9 (3·1) | 166 (56·5) | 7 (4·9) | 73 (50·7) |
Day 45 | 15 (5·1) | 181 (61·6) | 13 (9·0) | 86 (59·7) |
Day 60 | 16 (5·4) | 197 (67·0) | 6 (4·2) | 92 (63·9) |
Only first discharge is shown. Patients who were readmitted to hospital within 12 h were not counted as discharged.